[{"Assets_0_Q1_USD":"11119500000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.19","CommonStockSharesIssued_0_Q1_shares":"136000000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.47","EarningsPerShareDiluted_1_Q1_USD":"0.47","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","MinorityInterest_0_Q1_USD":"200000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"94500000.0","NetIncomeLoss_1_Q1_USD":"63900000.0","OfficialName":"Perrigo Company plc Ordinary Shares","PaymentsOfDividends_1_Q1_USD":"25900000.0","RevenuesConverted_1_Q1_USD":"1174500000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"5700800000.0","StockholdersEquity_0_Q1_USD":"5700600000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"136200000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"135900000.0","filed":"20190509","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"PERRIGO CO PLC","period":"20190331","qtrs":"0","uom":"USD"}]